Health
Healthy BMI tied to lower type 1 diabetes progression risk
The observational study followed 833 people with islet autoantibodies for about 4 years.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
The observational study followed 833 people with islet autoantibodies for about 4 years.
The test is for people with cognitive symptoms, not general health screening.
A Bristol-led trial found integrated online CBT lowered adult depression scores by 4.4 points after six months.
The hospital’s AI detects aspiration risk from vocal-cord changes after eating.
Masaki Mori’s JAIST team analyzed PI20 responses from 599 Japanese adults.
Candidate markers were identified directly in liver tissue using mass spectrometry and multi-omics.
Columbia researchers linked engineered human bone and lung tissues by vascular flow on one chip.
The review covered 35 studies and 2,108 patients with Lenke type 5 adolescent idiopathic scoliosis.
Dutch researchers found each extra year of brain-PAD raised dementia risk by 6%.
Researchers compared nearly 40,000 people with binge eating with more than 1.2 million unaffected people.
The candidate weakened norovirus by “unzipping” folded parts of its genome.
POSTECH’s soft patch emits therapeutic red light from room light or sunlight, without batteries or external power.
The compound activated PKGIα in animal models and engineered human heart tissue.
The UW–Madison device fits inside a Medtronic Micra leadless pacemaker.
Regeneron’s drug targets FOP, which progressively locks patients’ limbs by causing bone to form in soft tissue.
The database covers 2,363 people at licensed centers, including users outside tightly screened clinical trials.
About 50 adults aged 18–36 completed six one-minute bouts at a relatively intense pace.
The 28-day test involved 45 male mice, not people.